The role of oral contraception use in the occurrence of breast cancer. A retrospective study of 405 patients

Clinical and Experimental Obstetrics and Gynecology

Volumn 38, Issue 3, 2011, Pages 225-227

  Iatrakis, G ^a   Iavazzo, C ^b   Zervoudis, S ^c   Koumousidis, A ^d   Sofoudis, C ^b   Kalampokas, T ^b   Salakos, N ^b  

^a UNIVERSITY OF WEST ATTICA   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c Lito Maternity Hospital   (Greece)

^d TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

Author keywords

BRCA mutation carriers; Breast cancer; Oral contraceptives; Prolonged use; Risk factor

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; DRUG USE; FEMALE; GENE MUTATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TUMOR SUPPRESSOR GENE;

ADULT; BREAST NEOPLASMS; CONTRACEPTIVES, ORAL; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GREECE; HETEROZYGOTE; HUMANS; MIDDLE AGED; MUTATION; NEOPLASMS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 80054115702     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J.: "Cancer statistics, 2009". CA Cancer J. Clin., 2009, 59, 225.
2. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., Thun M.J.: "Cancer statistics, 2009". CA Cancer J. Clin., 2006, 56, 106.
3. Anderson W.F., Chu K.C., Devesa S.S.: "Distinct incidence patterns among in situ and invasive breast carcinomas,with possible etiologic implications". Breast Cancer Res. Treat., 2004, 88, 149.
4. Arpino G., Bardou V.J., Clark G.M., Elledge R.M.: "Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome". Breast Cancer Res., 2004, 6, R149.
5. Hulka B.S., Moorman P.G.: "Breast cancer: hormones and other risk factors". Maturitas., 2001, 38, 103.
6. Pasanisi P., Hédelin G., Berrino J., Chang-Claude J., Hermann S., Steel M. et al.: "Oral contraceptive use and BRCA penetrance: a case-only study". Cancer Epidemiol Biomarkers Prev., 2009, 18, 2107.
7. Lumachi F, Frigo A.C., Basso U., Tombolan V., Ermani M.: "Estrogen therapy and risk of breast cancer in postmenopausal women: a case-control study and results of a multivariate analysis". Menopause, 2010, 17, 524.
8. Braendle W., Kuhl H., Mueck A., Birkhäuser M., Thaler C., Kiesel L., Neulen J.: "Does hormonal contraception increase the risk for tumors?". Ther. Umsch., 2009, 66, 129 (in German).
9. U.S. Preventive Services Task Force: "Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement". Ann. Intern. Med., 2005, 143, 355. Erratum in Ann. Inter. Med., 2005, 143, 547.
10. Lončar D.: "Oral hormonal contraception - the influence on human genome and lipid status". Acta Medica Medianae, 2007, 46, 11.